A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This study was designed to find out how effective and safe GW786034, is in the treatment of
epithelial ovarian, fallopian tube, or primary peritoneal cancer that has not responded to
standard treatment.